Robert Jones
Chief Executive Officer at ACURA PHARMACEUTICALS, INC.
Net worth: - $ as of 2023-12-30
Profile
Robert B.
Jones is currently the President, Chief Executive Officer & Director at Acura Pharmaceuticals, Inc. He previously worked as the VP-Finance, Strategy & Business Analysis at Adolor Corp.
from 2003 to 2008.
He also held the position of Vice President-Marketing & Business Development at Endeavor Pharmaceuticals, Inc. and Vice President-Sales & Marketing at Purepac Pharmaceutical Co. Additionally, he served as the Chief Operating Officer & Vice President-Finance at Opt-e-scrip, Inc. from 2000 to 2003.
Mr. Jones completed his undergraduate degree at Cornell University and holds an MBA from The University of North Carolina at Charlotte.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-11-19 | 643,555 ( 0.98% ) | - $ | 2023-12-30 |
Robert Jones active positions
Companies | Position | Start |
---|---|---|
ACURA PHARMACEUTICALS, INC. | Chief Executive Officer | 2011-03-31 |
Former positions of Robert Jones
Companies | Position | End |
---|---|---|
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Corporate Officer/Principal | 2008-02-29 |
Opt-e-scrip, Inc. | Director of Finance/CFO | 2003-04-30 |
Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endeavor Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on women's health by developing and marketing advanced hormone therapies. The company is headquartered in Wilmington, NC. | Sales & Marketing | - |
Purepac Pharmaceutical Co.
Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Purepac Pharmaceutical Co. a subsidiary of Actavis Group Hf. Alpharma U.S. Human Pharmaceuticals and Purepac Pharmaceuticals have now become Actavis Group Hf. Purepac Pharmaceuticals manufactures generic equivalent drugs for cardiovascular, inflammatory, and central nervous system disorders. The company was headquartered in Elizabeth, NJ. | Sales & Marketing | - |
Training of Robert Jones
Cornell University | Undergraduate Degree |
The University of North Carolina at Charlotte | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ACURA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 4 |
---|---|
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endeavor Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on women's health by developing and marketing advanced hormone therapies. The company is headquartered in Wilmington, NC. | Health Technology |
Purepac Pharmaceutical Co.
Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Purepac Pharmaceutical Co. a subsidiary of Actavis Group Hf. Alpharma U.S. Human Pharmaceuticals and Purepac Pharmaceuticals have now become Actavis Group Hf. Purepac Pharmaceuticals manufactures generic equivalent drugs for cardiovascular, inflammatory, and central nervous system disorders. The company was headquartered in Elizabeth, NJ. | Health Technology |
Opt-e-scrip, Inc. |
- Stock Market
- Insiders
- Robert Jones